Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (6): 1029-1033. doi: 10.19723/j.issn.1671-167X.2020.06.007

Previous Articles     Next Articles

Clinical characteristics and related factors of rheumatoid arthritis complicated with tuberculosis infection

Guo TANG1,Li LONG2,(),Ya-xin HAN3,Qing PENG4,Jia-jun LIU4,Hua SHANG4   

  1. 1. Department of Rheumatology and Immunology, The Bishan Hospital of Chongqing, Chongqing 402760, China
    2. Department of Rheumatology and Immunology, Sichuan Provincial People’s Hospital, Chengdu 610000, China
    3. Department of Rheumatology and Immunology, The People’s Hospital of Wenjiang, Chendu 610000, China
    4. The First Clinical Institute, Zunyi Medical University, Zunyi 563000, Guizhou, China
  • Received:2020-07-30 Online:2020-12-18 Published:2020-12-13
  • Contact: Li LONG E-mail:llllyyyy2012@sina.com

Abstract:

Objective: To investigate the clinical characteristics and high risk factors of Rheumatoid arthritis (RA) complicated with tuberculosis infection. Methods: Patients with rheumatoid arthritis diagnosed in the hospital of Sichuan Provincial People’s Hospital from January 2007 to January 2017 was retrospectively collected, who were enrolled in the study group. A control group was randomly selected from the RA patients hospitalized in the same period without co-infection at a ratio of 1:2. The general data, clinical data, laboratory test data, treatment plan, etc. of the two groups were collected in detail for single factor statistical analysis. Then multivariate Logistic regression was used to analyze the independent risk factors of RA complicated with tuberculosis infection with statistical significance in univariate analysis. Results: The clinical manifestations of fever (83.3%) were most common, followed by cough (69%) and body mass loss (45.2%). In the infected group, pulmonary tuberculosis accounted for 73.3%. In the infected group the chest CT showed two or more cases, accounting for 59%. There were 9 cases (33.3%) occurring in the typical tuberculosis occurrence site. Compared with the control group, the erythrocyte sedimentation rate (ESR), C-reaction protein (CRP) levels, and the daily average dose of glucocorticoid in 1 year in the infected group were higher than those in the control group. And those differences were statistically significant(P<0.05). There were no significant differences in gender, age, disease duration, disease activity score, white blood cell (WBC), platelet (PLT), hemoglobin (Hb), immunoglobulin G (IgG), complement (C), Anti cyclic citrullinated peptide antibody (anti-CCP), CD4+T cell count, and immunosuppressant use (P>0.05). Multivariate Logistic regression analysis showed that CRP levels(OR=1.016, 95%CI:1.002-1.031) and the daily average dose of glucocorticoid in 1 year(OR=1.229, 95%CI:1.066-1.418)were the independent risk factors of RA complica-ted with tuberculosis infection. Conclusion: RA patients with tuberculosis infection are mainly phthisis. The clinical manifestations of RA combined with tuberculosis infection are lack of specificity, and the chest imaging features of pulmonary tuberculosis are diverse, which are easy to be misdiagnosed. CRP levels and the daily average dose level of glucocorticoid in 1 year were risk factors for RA and tuberculosis infection.

Key words: Rheumatoid arthritis, Tuberculosis, Risk factor

CLC Number: 

  • R593

Table 1

Multivariate Logistic regressionanalysis of the related factors of RA complicated with tuberculosis"

Characteristic B SE P OR (95%CI)
CRP 0.016 0.007 0.030 1.016 (1.002, 1.031)
ESR 0.008 0.011 0.486 1.008 (0.986, 1.030)
Average daily dose of glucocorticoid 0.206 0.073 0.005 1.229 (1.066, 1.418)
[1] Justin L, Warren F, Wijaya L, et al. Disseminated tuberculosis masquerading as a presentation of systemic lupus erythematosus[J]. Int J Rheum Dis, 2018,21(1):352-355.
pmid: 28971575
[2] World Health Organization. Global Tuberculosis Report 2019[EB/OL].(2019-12-12)[2020-04-10]. https://www.who.int/tb/publications/global_report/en.
[3] 刘二勇, 周林, 成诗明. 结核分枝杆菌潜伏性感染及预防性治疗研究进展的系统评价[J]. 中国防痨杂志, 2013,35(4):231-239.
[4] Chung T, Ko H, Lau C, et al. A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis[J]. Rheumatol Int, 2020,40(6):983-990.
pmid: 32318800
[5] Christy H, Mike O, Jessie B, et al. Finding the missing patients with tuberculosis: lessons learned from patient-pathway analyses in 5 countries[J]. J Infect Dis, 2017,216(7):686-695.
[6] Handa R, Upadhyaya S, Kapoor S, et al. Tuberculosis and biologics in rheumatology: A special situation[J]. Int J Rheum Dis, 2017,51(10):115.
[7] Chin DP, Hanson C L. Finding the missing tuberculosis patients[J]. J Infect Dis, 2017,216(7):675-678.
[8] Balsa A, Carmona L, González-Alvaro I, et al. Value of disease activity score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.[J]. J Rheumatol, 2004,31(1):40.
pmid: 14705217
[9] 中华人民共和国国家卫生健康委员会. 结核病分类(WS196—2017)[J]. 新发传染病电子杂志, 2018,3(3):191-192.
[10] 中华人民共和国国家卫生健康委员会. 肺结核诊断标准(WS 288—2017)[J]. 新发传染病电子杂志, 2018,3(1):59-61.
[11] Franco MD, Lucchino B, Spaziant M, et al. Lung infections in systemic rheumatic disease: focus on opportunistic infections.[J]. Int J Mol Sci, 2017,18(2):293.
[12] Ni Mhuircheartaigh OM, Matteson EL, Green AB, et al. Trends in serious infections in rheumatoid arthritis[J]. J Rheumatol, 2013,40(5):611-616.
doi: 10.3899/jrheum.121075 pmid: 23547208
[13] Anton C, Machado FD, Ramirez JMA, et al. Latent tuberculosis infection in patients with rheumatic diseases[J]. J Bras Pneumol, 2019,45(2):e20190023.
doi: 10.1590/1806-3713/e20190023 pmid: 31038654
[14] 邓国防, 王玉香, 陈涛, 等. 风湿免疫性疾病并发结核感染的临床特征分析[J]. 中国防痨杂志, 2018,40(4):392-396.
[15] Hong LC, Hsin-Hua C, Yi-Hsing C, et al. The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.[J]. PLoS One, 2017,12(6):e0178035.
doi: 10.1371/journal.pone.0178035 pmid: 28570568
[16] Youssef J, Novosad SA, Winthrop KL, et al. Infection risk and safety of corticosteroid use[J]. Clin Rheum Dis, 2016,42(1):157-176.
[1] SU Jun-qi,SONG Yang,XIE Shang. Analysis of etiological characteristics and establishment of prediction model of postoperative infections in patients undergoing oral squamous cell carcinoma surgery with free flap reconstruction [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 68-76.
[2] Lu ZHANG,Xiao-hong HU,Cheng CHEN,Yue-ming CAI,Qing-wen WANG,Jin-xia ZHAO. Analysis of cervical instability and clinical characteristics in treatment-naive rheumatoid arthritis patients [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1049-1054.
[3] Liang LUO,Wen-gang HUO,Qin ZHANG,Chun LI. Clinical characteristics and risk factors of rheumatoid arthritis with ulcerative keratitis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1032-1036.
[4] Hua ZHONG,Li-ling XU,Ming-xin BAI,Yin SU. Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1026-1031.
[5] Xue LOU,Li LIAO,Xing-jun LI,Nan WANG,Shuang LIU,Ruo-mei CUI,Jian XU. Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1020-1025.
[6] Hao XU,Guo-dong ZHANG,Guang-pu FAN,Yu CHEN. Preoperative plasma predictive factors of new-onset atrial fibrillation after coronary artery bypass graft surgery: A propensity score matching study [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1139-1143.
[7] Zhan-yue NIU,Yan XUE,Jing ZHANG,He-jun ZHANG,Shi-gang DING. Analysis of endoscopic and pathological features of gastric adenomatous polyps and risk factors for canceration [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1122-1127.
[8] Jing-xian ZHU,Sheng-nan LU,Yan-fang JIANG,Ling JIANG,Jian-quan WANG. Influencing factors of preoperative pulmonary function in elderly patients undergoing rotator cuff surgery [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 902-906.
[9] WANG Jia-wen,LIU Jing-chao,MENG Ling-feng,ZHANG Wei,LIU Xiao-dong,ZHANG Yao-guang. Quality of life and related factors in patients with interstitial cystitis/bladder pain syndrome [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 653-658.
[10] SUN Zheng-hui,HUANG Xiao-juan,DONG Jing-han,LIU Zhuo,YAN Ye,LIU Cheng,MA Lu-lin. Risk factors of renal sinus invasion in clinical T1 renal cell carcinoma patients undergoing nephrectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 659-664.
[11] ZHOU Bo-lin,LI Wei-shi,SUN Chui-guo,QI Qiang,CHEN Zhong-qiang,ZENG Yan. Risk factors for multiple debridements of the patients with deep incisional surgical site infection after spinal surgery [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 286-292.
[12] ZHAO Kai,CHANG Zhi-fang,WANG Zhi-hua,PANG Chun-yan,WANG Yong-fu. Therapeutic effect of gene silencing peptidyl arginine deaminase 4 on pulmonary interstitial lesions induced by collagen-induced arthritis mice [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 235-239.
[13] CAO Di,WANG Yan,WANG Liu-qing,SUN Xiao-lin,HUANG Fei,MENG Yang,REN Li-li,ZHANG Xue-wu. Expression of plasma Dickkopf-1 in patients with rheumatoid arthritis and its correlation with peripheral blood T cell subsets [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 255-260.
[14] XIA Fang-fang,LU Fu-ai,LV Hui-min,YANG Guo-an,LIU Yuan. Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 266-272.
[15] FENG Jing-nan,GAO Le,SUN Yi-xin,YANG Ji-chun,DENG Si-wei,SUN Feng,ZHAN Si-yan. Accuracy of Xpert®MTB/RIF for the detection of tuberculosis and rifampicin-resistance tuberculosis in China: A systematic review and meta-analysis [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 320-326.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 351 -354 .